Recon: Pfizer withdraws sickle cell drug Oxbryta from worldwide markets; Evotec, Novo Nordisk partner on stem cell therapy manufacturing
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeEuropean Medicines Agency (EMA)GlobalMarket withdrawalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States